Skip to content

Megan Wood

Megan Wood is an experienced news writer at Med Pharma News, with over a decade of expertise in healthcare journalism. She has covered a wide range of topics, including public health policy, medical research advancements, and global healthcare systems. Megan's work has been featured in top online publications. Known for her thorough investigative skills and ability to translate complex medical information into accessible content, Megan has earned recognition as a leading voice in healthcare reporting. She currently resides in Boston, where she continues to report on the latest developments in the medical field.

Novo Holdings Commits USD 100 Million Investment in Asceneuron

Novo Holdings Commits USD 100 Million Investment in Asceneuron

Novo Holdings has announced a $100 million investment in Swiss biotech firm Asceneuron, aimed at accelerating the development of innovative treatments for neurodegenerative diseases. This strategic funding highlights the potential impact of Asceneuron’s research on the biotech industry and patient care.